Rocacetrapib
- Generic Name
- Rocacetrapib
- Drug Type
- Small Molecule
- Chemical Formula
- C31H34F7NO3
- CAS Number
- 1402796-27-3
- Unique Ingredient Identifier
- K9SP3L3YQP
- Background
Rocacetrapib is under investigation in clinical trial NCT02156544 (Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519).
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
- First Posted Date
- 2017-07-07
- Last Posted Date
- 2017-07-07
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 18
- Registration Number
- NCT03210649
- Locations
- 🇰🇷
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 24
- Registration Number
- NCT02753504
- Locations
- 🇰🇷
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2015-09-11
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 41
- Registration Number
- NCT02156544
- Locations
- 🇰🇷
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath